FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of February, 2004
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Holding(s) in Company dated 05 February 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
|
Celltech Group plc |
2. Name of shareholder having a major interest
|
The Capital Group Companies, Inc. |
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
|
As in 2 above |
4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
|
State Street Nominees Ltd |
4,500 |
|
Chase Nominees Ltd |
2,227,403 |
|
Citibank London |
106,100 |
|
Nortrust Nominees |
992,000 |
|
Mellon Nominees (UK) Ltd |
141,500 |
|
State Street Nominees Ltd |
457,900 |
|
Bank of New York Nominees |
6,818,607 |
|
Northern Trust |
1,520,302 |
|
Chase Nominees Ltd |
2,946,063 |
|
Midland Bank plc |
168,500 |
|
Bankers Trust |
429,200 |
|
Barclays Bank |
60,000 |
|
Citibank London |
53,000 |
|
Morgan Guaranty |
441,500 |
|
Nortrust Nominees |
3,664,238 |
|
State Street Bank & Trust Co |
2,054,693 |
|
Deutsche Bank AG |
1,459,800 |
|
HSBC Bank plc |
1,308,300 |
|
Mellon Bank N.A. |
230,300 |
|
Northern Trust AVFC |
196,436 |
|
KAS UK |
64,810 |
|
Mellon Nominees (UK) Ltd |
63,500 |
|
Bank One London |
141,400 |
|
State Street Nominees Ltd |
58,000 |
|
Bank of New York Nominees |
82,000 |
|
Chase Nominees Ltd |
2,652,391 |
|
Midland Bank plc |
534,500 |
|
Barclays Bank |
566,900 |
|
Citibank London |
23,700 |
|
Brown Bros. |
51,500 |
|
Royal Bank of Scotland |
1,238,200 |
|
State Street Bank & Trust Co. |
80,400 |
|
Lloyds Bank |
83,100 |
|
RBSTB Nominees Ltd |
133,300 |
|
Citibank NA |
17,600 |
|
HSBC Bank plc |
381,100 |
|
State Street Nominees Ltd |
1,306,259 |
|
Bank of New York Nominees |
200,468 |
|
Chase Nominees Ltd |
851,000 |
|
Midland Bank plc |
153,700 |
|
Deutsche Bank Mannheim |
48,000 |
|
Bankers Trust |
18,300 |
|
Citibank London |
52,000 |
|
Nortrust Nominees |
514,023 |
|
Royal Bank of Scotland |
129,500 |
|
State Street Bank & Trust Co |
342,599 |
|
RBSTB Nominees Ltd |
26,300 |
|
Citibank NA |
98,400 |
|
Deutsche Bank AG |
31,200 |
|
HSBC Bank plc |
189,709 |
|
State Street Nominees Ltd |
2,987,133 |
5. Number of shares / amount of stock acquired
|
N/a |
6. Percentage of issued class
|
N/a |
7. Number of shares / amount of stock disposed
|
2,702,106 (since last notification) |
8. Percentage of issued class
|
0.97% |
9. Class of security
|
Ordinary 50p Shares |
10. Date of transaction
|
3 February 2004 |
11. Date company informed
|
5 February 2004 |
12. Total holding following this notification
|
38,401,334 |
13. Total percentage holding of issued class following this notification
|
13.82% |
14. Any additional information
|
- |
15. Name of contact and telephone number for queries
|
Anita Dowling (01753) 777106 |
16. Name and signature of authorised company official responsible for making this notification
|
J A D Slater |
Date of notification
|
5 February 2004 |
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 16 February 2004